Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  33 results for ""HIV Protease Inhibitors""

Your Filters

Content Provider : MEDLINE Geographic : united states
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Virtual screening for HIV protease inhibitors: a comparison of AutoDock 4 and Vina.

  • Authors : Chang MW; Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, USA.; Ayeni C

Subjects: Software* ; User-Computer Interface*; Drug Evaluation, Preclinical/Drug Evaluation, Preclinical/Drug Evaluation, Preclinical/*methods

  • Source: PloS one [PLoS One] 2010 Aug 04; Vol. 5 (8), pp. e11955. Date of Electronic Publication: 2010 Aug 04.Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Electronic

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Bleeding episodes in HIV-positive patients taking HIV protease inhibitors: a case series.

  • Authors : Racoosin JA; Food and Drug Administration, Center for Drug Evaluation and Research, USA.; Kessler CM

Subjects: HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*adverse effects ; HIV Seropositivity/HIV Seropositivity/HIV Seropositivity/*complications ; Hemophilia A/Hemophilia A/Hemophilia A/*complications

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 1999 Jul; Vol. 5 (4), pp. 266-9.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print Cited Medium: Print ISSN: 1351-8216 (Print)

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada.

Subjects: HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV Integrase Inhibitors/HIV Integrase Inhibitors/HIV Integrase Inhibitors/*adverse effects ; HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*adverse effects

  • Source: Journal of the International AIDS Society [J Int AIDS Soc] 2020 Apr; Vol. 23 (4), pp. e25484.Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Periodical

NIH denies march-in rights on Norvir patent.

Subjects: HIV Protease Inhibitors*/HIV Protease Inhibitors*/HIV Protease Inhibitors*/therapeutic use ; Ritonavir*/Ritonavir*/Ritonavir*/therapeutic use; National Institutes of Health (U.S.)/National Institutes of Health (U.S.)/National Institutes of Health (U.S.)/*legislation & jurisprudence

  • Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2013 Dec; Vol. 12 (12), pp. 898.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Comparison of the molecular dynamics and calculated binding free energies for nine FDA-approved HIV-1 PR drugs against subtype B and C-SA HIV PR.

  • Authors : Ahmed SM; School of Health Sciences, University of KwaZulu-Natal, Durban 4001, South Africa.; Kruger HG

Subjects: HIV Protease/HIV Protease/HIV Protease/*chemistry ; HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*chemistry ; HIV-1/HIV-1/HIV-1/*drug effects

  • Source: Chemical biology & drug design [Chem Biol Drug Des] 2013 Feb; Vol. 81 (2), pp. 208-18. Date of Electronic Publication: 2012 Nov 19.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Cost effectiveness of lopinavir/ritonavir compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the US.

  • Authors : Simpson KN; Department of Health Administration and Policy, College of Health Professions, Medical University of South Carolina, Charleston, SC 29425, USA. ; Jones WJ

Subjects: Antiretroviral Therapy, Highly Active*; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV Infections/HIV Infections/HIV Infections/*economics

  • Source: Clinical drug investigation [Clin Drug Investig] 2007; Vol. 27 (7), pp. 443-52.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.

Subjects: Antiretroviral Therapy, Highly Active*; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*therapeutic use

  • Source: Lancet (London, England) [Lancet] 2006 Dec 16; Vol. 368 (9553), pp. 2125-35.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic)

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Simplifying the treatment of HIV infection with ritonavir-boosted protease inhibitors in antiretroviral-experienced patients.

  • Authors : Scott JD; Western University of Health Sciences, 309 East 2nd Street, Pomona, CA 91766, USA.

Subjects: HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*therapeutic use ; Ritonavir/Ritonavir/Ritonavir/*therapeutic use

  • Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2005 Apr 15; Vol. 62 (8), pp. 809-15.Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Print ISSN: 1079-2082

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women.

  • Authors : Conradie F; HIV Clinical Trial Unit, Helen Joseph Hospital, University of Witwaterand, Westdene, South Africa.; Zorrilla C

Subjects: HIV-1*/HIV-1*/HIV-1*/immunology; HIV Infections/HIV Infections/HIV Infections/*prevention & control ; HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*pharmacokinetics

  • Source: HIV medicine [HIV Med] 2011 Oct; Vol. 12 (9), pp. 570-9. Date of Electronic Publication: 2011 May 16.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Validation of the HIV treatment satisfaction questionnaire (HIVTSQ).

  • Authors : Woodcock A; Department of Psychology, University of London, Egham, Surrey, England, UK. ; Bradley C

Subjects: Quality of Life* ; Sickness Impact Profile* ; Surveys and Questionnaires*

  • Source: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2001; Vol. 10 (6), pp. 517-31.Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 9210257 Publication Model: Print Cited Medium: Print ISSN: 0962-9343

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  33 results for ""HIV Protease Inhibitors""